Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-Alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1
XXXX|更新时间:2025-04-28
|
Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-Alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1
“According to the latest report, a study conducted by the Department of Spleen, Stomach, Liver and Gallbladder Diseases at the First Affiliated Hospital of Henan University of Traditional Chinese Medicine has found that Xiaozhi Hugan Capsules have significant therapeutic effects on patients with phlegm dampness stasis type non-alcoholic fatty liver disease. They can reduce liver hardness and inhibit the expression of inflammatory factors, which is worth promoting.”
Chinese Journal of Experimental Traditional Medical FormulaePages: 1-8(2025)
LIU Xiaoyan, MA Suping, MA Qingliang, et al. Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-Alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1[J/OL]. Chinese journal of experimental traditional medical formulae, 2025, 1-8.
DOI:
LIU Xiaoyan, MA Suping, MA Qingliang, et al. Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-Alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1[J/OL]. Chinese journal of experimental traditional medical formulae, 2025, 1-8. DOI: 10.13422/j.cnki.syfjx.20251198.
Clinical Effect of Xiaozhi Hugan Capsules in Treatment of Patients with Non-Alcoholic Steatohepatitis and Its Impact on Serum IL-6 and MCP-1